Status:

COMPLETED

Premenstrual Dysphoric Disorder and Antiepileptic Drugs

Lead Sponsor:

Beth Israel Deaconess Medical Center

Collaborating Sponsors:

Newton-Wellesley Hospital

Brigham and Women's Hospital

Conditions:

Epilepsy

Eligibility:

FEMALE

18-45 years

Brief Summary

This study is being done to determine if there are differences in mood during the menstrual cycle among women with epilepsy who take various different antiepileptic drugs and women without epilepsy.

Detailed Description

Participants will be given informed consent during the initial study visit. We will gather information about their seizure disorder and medications and provide them with instructions and a form that t...

Eligibility Criteria

Inclusion

  • Women with epilepsy, 18-45 years of age. Women will be on one of 4 established (≥ 3 months) AED monotherapies: LTG, CBZ, PHT or LEV and with documented therapeutic range serum AED level during the year prior to enrollment.
  • Normal Control women, 18-45 years of age, in good general health by history

Exclusion

  • Concomitant use of prescribed or OTC reproductive hormones
  • Concomitant use of antidepressant and anxiolytic medications such as SSRIs, bupropion, tricyclics, benzodiazepines

Key Trial Info

Start Date :

April 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00612235

Start Date

April 1 2008

End Date

June 1 2010

Last Update

October 26 2018

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02215

3

Newton-Wellesley Hospital

Newton, Massachusetts, United States, 02462